Do antivirals have any utility in the treatment of arthritis?

T Pap1, R E Gay, S Gay

  • 1WHO Collaborating Center for Molecular Biology and Novel Therapeutic Strategies for Rheumatic Diseases, Center for Experimental Rheumatology, Department of Rheumatology, University Hospital, Gloriastrasse 25, CH-8091 Zurich, Switzerland.

Insights

Viruses may directly cause arthritis or contribute to rheumatoid arthritis pathogenesis. Research is exploring antiviral therapies for chronic arthritis, though their use remains limited to specific cases and experimental studies.

Area of Science:

  • Virology
  • Rheumatology
  • Immunology

Background:

  • Viruses are implicated in various arthritides through direct infection or indirect mechanisms.
  • Circumstantial evidence suggests (retro)viral involvement in rheumatoid arthritis pathogenesis.
  • The precise mechanisms linking viral infections to rheumatoid arthritis are still under investigation.

Purpose of the Study:

  • To review current understanding of viral involvement in arthritis.
  • To explore the potential of antiviral agents in treating arthritis.
  • To identify future research directions for antiviral therapies in rheumatology.

Main Methods:

  • Literature review of studies on viral infections and arthritis.
  • Analysis of evidence for (retro)viral roles in rheumatoid arthritis.
  • Examination of current and experimental applications of antiviral agents.

Main Results:

  • Direct viral causation of arthritis is established for some pathogens.
  • Evidence for (retro)viral induction of rheumatoid arthritis is emerging but not fully elucidated.
  • The use of antiviral agents is currently restricted.

Conclusions:

  • Further research is needed to confirm persistent viral infections as a cause of chronic arthritis.
  • Understanding viral mechanisms is crucial for developing effective antiviral treatments for arthritis.
  • Antiviral therapies hold potential but require more investigation for broader arthritis applications.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...